ID   P5CR2_HUMAN             Reviewed;         320 AA.
AC   Q96C36; A8K798; Q7Z515; Q9Y5J4;
DT   01-MAR-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   10-MAY-2017, entry version 134.
DE   RecName: Full=Pyrroline-5-carboxylate reductase 2;
DE            Short=P5C reductase 2;
DE            Short=P5CR 2;
DE            EC=1.5.1.2;
GN   Name=PYCR2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Yue P., Yu L., Zhao S.Y.;
RT   "Cloning of a new human cDNA homologous to human pyrroline 5-
RT   carboxylate reductase mRNA.";
RL   Submitted (AUG-1998) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cervix, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 2-17, CLEAVAGE OF INITIATOR METHIONINE,
RP   ACETYLATION AT SER-2, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Colon carcinoma;
RA   Bienvenut W.V., Heiserich L., Gottlieb E., Zebisch A., Kolch W.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, ENZYME REGULATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=6894153; DOI=10.1172/JCI110115;
RA   Yeh G.C., Harris S.C., Phang J.M.;
RT   "Pyrroline-5-carboxylate reductase in human erythrocytes.";
RL   J. Clin. Invest. 67:1042-1046(1981).
RN   [8]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBUNIT, SUBCELLULAR LOCATION, ENZYME
RP   REGULATION, BIOPHYSICOCHEMICAL PROPERTIES, AND TISSUE SPECIFICITY.
RX   PubMed=2722838;
RA   Merrill M.J., Yeh G.C., Phang J.M.;
RT   "Purified human erythrocyte pyrroline-5-carboxylate reductase.
RT   Preferential oxidation of NADPH.";
RL   J. Biol. Chem. 264:9352-9358(1989).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-304, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-304, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-304, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [15]
RP   SUBCELLULAR LOCATION.
RX   PubMed=23024808; DOI=10.1371/journal.pone.0045190;
RA   De Ingeniis J., Ratnikov B., Richardson A.D., Scott D.A.,
RA   Aza-Blanc P., De S.K., Kazanov M., Pellecchia M., Ronai Z.,
RA   Osterman A.L., Smith J.W.;
RT   "Functional specialization in proline biosynthesis of melanoma.";
RL   PLoS ONE 7:E45190-E45190(2012).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-304, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, INVOLVEMENT IN
RP   HLD10, VARIANTS HLD10 CYS-119 AND CYS-251, AND CHARACTERIZATION OF
RP   VARIANTS HLD10 CYS-119 AND CYS-251.
RX   PubMed=25865492; DOI=10.1016/j.ajhg.2015.03.003;
RA   Nakayama T., Al-Maawali A., El-Quessny M., Rajab A., Khalil S.,
RA   Stoler J.M., Tan W.H., Nasir R., Schmitz-Abe K., Hill R.S.,
RA   Partlow J.N., Al-Saffar M., Servattalab S., LaCoursiere C.M.,
RA   Tambunan D.E., Coulter M.E., Elhosary P.C., Gorski G., Barkovich A.J.,
RA   Markianos K., Poduri A., Mochida G.H.;
RT   "Mutations in PYCR2, encoding pyrroline-5-carboxylate reductase 2,
RT   cause microcephaly and hypomyelination.";
RL   Am. J. Hum. Genet. 96:709-719(2015).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Housekeeping enzyme that catalyzes the last step in
CC       proline biosynthesis. In some cell types, such as erythrocytes,
CC       its primary function may be the generation of NADP(+). Can utilize
CC       both NAD and NADP. Has higher affinity for NADP, but higher
CC       catalytic efficiency with NADH (PubMed:2722838, PubMed:6894153).
CC       Involved in cellular response to oxidative stress
CC       (PubMed:25865492). {ECO:0000269|PubMed:25865492,
CC       ECO:0000269|PubMed:2722838, ECO:0000269|PubMed:6894153}.
CC   -!- CATALYTIC ACTIVITY: L-proline + NAD(P)(+) = 1-pyrroline-5-
CC       carboxylate + NAD(P)H. {ECO:0000269|PubMed:2722838,
CC       ECO:0000269|PubMed:6894153}.
CC   -!- ENZYME REGULATION: Subject to competitive inhibition by NADP. Not
CC       inhibited by proline. {ECO:0000269|PubMed:2722838,
CC       ECO:0000269|PubMed:6894153}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.64 mM for NADH {ECO:0000269|PubMed:2722838};
CC         KM=0.04 mM for NADPH {ECO:0000269|PubMed:2722838};
CC         KM=1.49 mM for pyrroline-5-carboxylate (in the presence of NADH)
CC         {ECO:0000269|PubMed:2722838};
CC         KM=0.23 mM for pyrroline-5-carboxylate (in the presence of
CC         NADPH) {ECO:0000269|PubMed:2722838};
CC         Vmax=28.5 umol/min/ug enzyme (in the presence of NADH)
CC         {ECO:0000269|PubMed:2722838};
CC         Vmax=3.7 umol/min/ug enzyme (in the presence of NADPH)
CC         {ECO:0000269|PubMed:2722838};
CC   -!- PATHWAY: Amino-acid biosynthesis; L-proline biosynthesis; L-
CC       proline from L-glutamate 5-semialdehyde: step 1/1.
CC   -!- SUBUNIT: Homodecamer; composed of 5 homodimers.
CC       {ECO:0000305|PubMed:2722838}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:2722838}.
CC       Mitochondrion {ECO:0000269|PubMed:23024808,
CC       ECO:0000269|PubMed:25865492}.
CC   -!- TISSUE SPECIFICITY: Detected in erythrocytes (at protein level)
CC       (PubMed:2722838, PubMed:6894153). Expressed in fetal brain
CC       (PubMed:25865492). {ECO:0000269|PubMed:25865492,
CC       ECO:0000269|PubMed:2722838, ECO:0000269|PubMed:6894153}.
CC   -!- DISEASE: Leukodystrophy, hypomyelinating, 10 (HLD10) [MIM:616420]:
CC       An autosomal recessive neurologic disorder characterized by
CC       postnatal microcephaly, severely delayed psychomotor development,
CC       hypomyelination, and reduced cerebral white-matter volume.
CC       {ECO:0000269|PubMed:25865492}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the pyrroline-5-carboxylate reductase
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF087859; AAP97169.1; -; mRNA.
DR   EMBL; AK291913; BAF84602.1; -; mRNA.
DR   EMBL; AL117348; CAI21802.1; -; Genomic_DNA.
DR   EMBL; CH471098; EAW69762.1; -; Genomic_DNA.
DR   EMBL; BC014868; AAH14868.1; -; mRNA.
DR   EMBL; BC020553; AAH20553.1; -; mRNA.
DR   CCDS; CCDS31043.1; -.
DR   RefSeq; NP_001258610.1; NM_001271681.1.
DR   RefSeq; NP_037460.2; NM_013328.3.
DR   UniGene; Hs.654718; -.
DR   ProteinModelPortal; Q96C36; -.
DR   BioGrid; 118962; 32.
DR   IntAct; Q96C36; 19.
DR   MINT; MINT-1150827; -.
DR   STRING; 9606.ENSP00000342502; -.
DR   DrugBank; DB00172; L-Proline.
DR   DrugBank; DB00157; NADH.
DR   iPTMnet; Q96C36; -.
DR   PhosphoSitePlus; Q96C36; -.
DR   SwissPalm; Q96C36; -.
DR   DMDM; 60390642; -.
DR   EPD; Q96C36; -.
DR   MaxQB; Q96C36; -.
DR   PaxDb; Q96C36; -.
DR   PeptideAtlas; Q96C36; -.
DR   PRIDE; Q96C36; -.
DR   TopDownProteomics; Q96C36; -.
DR   DNASU; 29920; -.
DR   Ensembl; ENST00000343818; ENSP00000342502; ENSG00000143811.
DR   GeneID; 29920; -.
DR   KEGG; hsa:29920; -.
DR   UCSC; uc001hpq.5; human.
DR   CTD; 29920; -.
DR   GeneCards; MIR6741; -.
DR   GeneCards; PYCR2; -.
DR   H-InvDB; HIX0200217; -.
DR   HGNC; HGNC:30262; PYCR2.
DR   HPA; HPA056873; -.
DR   MalaCards; PYCR2; -.
DR   MIM; 616406; gene.
DR   MIM; 616420; phenotype.
DR   neXtProt; NX_Q96C36; -.
DR   OpenTargets; ENSG00000143811; -.
DR   PharmGKB; PA134881955; -.
DR   eggNOG; KOG3124; Eukaryota.
DR   eggNOG; COG0345; LUCA.
DR   GeneTree; ENSGT00390000007443; -.
DR   HOGENOM; HOG000230247; -.
DR   HOVERGEN; HBG053399; -.
DR   InParanoid; Q96C36; -.
DR   KO; K00286; -.
DR   OMA; FITVKPW; -.
DR   OrthoDB; EOG091G0KMI; -.
DR   PhylomeDB; Q96C36; -.
DR   Reactome; R-HSA-70614; Amino acid synthesis and interconversion (transamination).
DR   SABIO-RK; Q96C36; -.
DR   UniPathway; UPA00098; UER00361.
DR   GenomeRNAi; 29920; -.
DR   PRO; PR:Q96C36; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000143811; -.
DR   CleanEx; HS_PYCR2; -.
DR   ExpressionAtlas; Q96C36; baseline and differential.
DR   Genevisible; Q96C36; HS.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0004735; F:pyrroline-5-carboxylate reductase activity; EXP:Reactome.
DR   GO; GO:0008652; P:cellular amino acid biosynthetic process; TAS:Reactome.
DR   GO; GO:0034599; P:cellular response to oxidative stress; IMP:UniProtKB.
DR   GO; GO:0055129; P:L-proline biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0006561; P:proline biosynthetic process; IDA:UniProtKB.
DR   HAMAP; MF_01925; P5C_reductase; 1.
DR   InterPro; IPR008927; 6-PGluconate_DH_C-like.
DR   InterPro; IPR016040; NAD(P)-bd_dom.
DR   InterPro; IPR028939; P5C_Rdtase_cat_N.
DR   InterPro; IPR029036; P5CR_dimer.
DR   InterPro; IPR000304; Pyrroline-COOH_reductase.
DR   PANTHER; PTHR11645; PTHR11645; 1.
DR   Pfam; PF03807; F420_oxidored; 1.
DR   Pfam; PF14748; P5CR_dimer; 1.
DR   PIRSF; PIRSF000193; Pyrrol-5-carb_rd; 1.
DR   SUPFAM; SSF48179; SSF48179; 1.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   TIGRFAMs; TIGR00112; proC; 1.
DR   PROSITE; PS00521; P5CR; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Amino-acid biosynthesis; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Disease mutation; Leukodystrophy;
KW   Mitochondrion; NADP; Oxidoreductase; Phosphoprotein;
KW   Proline biosynthesis; Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000269|Ref.6}.
FT   CHAIN         2    320       Pyrroline-5-carboxylate reductase 2.
FT                                /FTId=PRO_0000187317.
FT   NP_BIND       6     11       NADP. {ECO:0000250}.
FT   NP_BIND      69     72       NADP. {ECO:0000250}.
FT   NP_BIND      95     97       NADP. {ECO:0000250}.
FT   BINDING      34     34       NADP; via carbonyl oxygen. {ECO:0000250}.
FT   BINDING      56     56       NADP. {ECO:0000250}.
FT   MOD_RES       2      2       N-acetylserine. {ECO:0000269|Ref.6}.
FT   MOD_RES     304    304       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   VARIANT     119    119       R -> C (in HLD10; severe decrease of
FT                                protein amount; does not affect
FT                                mitochondrial localization;
FT                                dbSNP:rs372781135).
FT                                {ECO:0000269|PubMed:25865492}.
FT                                /FTId=VAR_074608.
FT   VARIANT     251    251       R -> C (in HLD10; mild decrease of
FT                                homodimerization; does not affect
FT                                mitochondrial localization).
FT                                {ECO:0000269|PubMed:25865492}.
FT                                /FTId=VAR_074609.
FT   CONFLICT     13     13       Y -> N (in Ref. 1; AAP97169).
FT                                {ECO:0000305}.
FT   CONFLICT     23     24       GI -> AF (in Ref. 1; AAP97169).
FT                                {ECO:0000305}.
FT   CONFLICT     72     73       PH -> HI (in Ref. 1; AAP97169).
FT                                {ECO:0000305}.
SQ   SEQUENCE   320 AA;  33637 MW;  9348455A64CCE722 CRC64;
     MSVGFIGAGQ LAYALARGFT AAGILSAHKI IASSPEMNLP TVSALRKMGV NLTRSNKETV
     KHSDVLFLAV KPHIIPFILD EIGADVQARH IVVSCAAGVT ISSVEKKLMA FQPAPKVIRC
     MTNTPVVVQE GATVYATGTH ALVEDGQLLE QLMSSVGFCT EVEEDLIDAV TGLSGSGPAY
     AFMALDALAD GGVKMGLPRR LAIQLGAQAL LGAAKMLLDS EQHPCQLKDN VCSPGGATIH
     ALHFLESGGF RSLLINAVEA SCIRTRELQS MADQEKISPA ALKKTLLDRV KLESPTVSTL
     TPSSPGKLLT RSLALGGKKD
//
